Cargando…

High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?

Detalles Bibliográficos
Autores principales: Honore, Patrick M., Barreto Gutierrez, Leonel, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560687/
https://www.ncbi.nlm.nih.gov/pubmed/33052490
http://dx.doi.org/10.1186/s13613-020-00758-5
_version_ 1783595133628841984
author Honore, Patrick M.
Barreto Gutierrez, Leonel
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
De Bels, David
author_facet Honore, Patrick M.
Barreto Gutierrez, Leonel
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
De Bels, David
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-7560687
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-75606872020-10-19 High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT? Honore, Patrick M. Barreto Gutierrez, Leonel Kugener, Luc Redant, Sebastien Attou, Rachid Gallerani, Andrea De Bels, David Ann Intensive Care Letter to the Editor Springer International Publishing 2020-10-14 /pmc/articles/PMC7560687/ /pubmed/33052490 http://dx.doi.org/10.1186/s13613-020-00758-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Honore, Patrick M.
Barreto Gutierrez, Leonel
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
De Bels, David
High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
title High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
title_full High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
title_fullStr High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
title_full_unstemmed High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
title_short High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
title_sort high doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under crrt?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560687/
https://www.ncbi.nlm.nih.gov/pubmed/33052490
http://dx.doi.org/10.1186/s13613-020-00758-5
work_keys_str_mv AT honorepatrickm highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt
AT barretogutierrezleonel highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt
AT kugenerluc highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt
AT redantsebastien highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt
AT attourachid highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt
AT galleraniandrea highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt
AT debelsdavid highdosesoftigecyclineareassociatedwithsatisfactoryplasmaticandpulmonaryconcentrationsforthetreatmentofsevereinfectionsduetofullysusceptiblebacteriadoweneedevenhigherdosesinpatientsundercrrt